| 國立成功大學 |
2023 |
Clinical impact of minimal residual disease and genetic subtypes on the prognosis of childhood acute lymphoblastic leukemia
|
Yu, C.-H.;Jou, S.-T.;Su, Y.-H.;Coustan-Smith, E.;Wu, G.;Cheng, Cheng C.-N.;Lu, M.-Y.;Lin, K.-H.;Wu, K.-H.;Chen, S.-H.;Huang, F.-L.;Chang, H.-H.;Wang, J.-L.;Yen, H.-J.;Li, M.-J.;Chou, S.-W.;Ho, W.-L.;Liu, Y.-L.;Chang, Chang C.-C.;Lin, Z.-S.;Lin, C.-Y.;Chen, H.-Y.;Ni, Y.-L.;Lin, D.-T.;Lin, S.-W.;Yang, J.J.;Ni, Y.-H.;Pui, C.-H.;Yu, S.-L.;Yang, Yang Y.-L. |
| 國立臺灣大學 |
2013 |
Clinical impact of pre- and post-transplant residual disease status detected by multidimensional flow cytometry in 120 adult patients with acute leukaemia
|
Li, C. C.; Tang, J. L.; Lin, C. T.; Yao, M.; Ko, B. S.; Wu, S. J.; Huang, S. Y.; Liu, J. H.; Chou, W. C.; Hou, H. A.; Tien, H. F.; Loken, M. R.; 姚明; 柯博升; 田蕙芬; 黃聖懿; 吳尚儒; 唐季祿; 周文堅; 侯信安 |
| 國立臺灣大學 |
1998-05-28 |
Clinical impact of screening first-degree relatives of patients with hepatocellular carcinoma
|
Chang, Shan-Chwen; Fang, Chi-Tai; Hsueh, Po-Ren; Liu, Chieh-Ju; Sheng, Wang-Huei; Hsieh, Szu-Min; Hung, Chien-Chin; Chen, Yee-Chun |
| 臺大學術典藏 |
2018-09-10T06:51:59Z |
Clinical impact of screening first-degree relatives of patients with hepatocellular carcinoma
|
PEI-MING YANG; DING-SHINN CHEN; GUAN-TARN HUANG; JIN-CHUAN SHEU; HSUAN-SHU LEE; Sheu, J.-C.; Chen, D.-S.; Yang, P.-M.; Lee, H.-S.; Huang, G.-T.; Chen, C.-H.; Chen, C.-H.;Huang, G.-T.;Lee, H.-S.;Yang, P.-M.;Chen, D.-S.;Sheu, J.-C. |
| 臺大學術典藏 |
2020-02-10T08:59:34Z |
Clinical impact of screening first-degree relatives of patients with hepatocellular carcinoma
|
Chen C.-H.;Huang G.-T.;Lee H.-S.;Yang P.-M.;Chen D.-S.;Sheu J.-C.; Chen C.-H.; Huang G.-T.; Lee H.-S.; Yang P.-M.; Chen D.-S.; Sheu J.-C.; HSUAN-SHU LEE |
| 臺大學術典藏 |
2021-02-02T06:41:23Z |
Clinical impact of screening first-degree relatives of patients with hepatocellular carcinoma
|
Chen C.-H.; Huang G.-T.; Lee, Hsuan-Shu; Yang P.-M.; Chen D.-S.; Sheu J.-C. |
| 臺大學術典藏 |
2022-02-23T02:12:48Z |
Clinical impact of screening first-degree relatives of patients with hepatocellular carcinoma
|
CHIEN-HUNG CHEN; Huang G.-T.; Lee H.-S.; Yang P.-M.; Chen D.-S.; Sheu J.-C. |
| 臺大學術典藏 |
2022-02-22T05:34:44Z |
Clinical impact of screening first-degree relatives of patients with hepatocellular carcinoma
|
CHIEN-HUNG CHEN; Huang G.-T.; Lee H.-S.; Yang P.-M.; Chen D.-S.; Sheu J.-C. |
| 臺大學術典藏 |
2021-04-22T06:56:57Z |
Clinical impact of screening first-degree relatives of patients with hepatocellular carcinoma
|
Chen C.-H.; Huang G.-T.; Lee H.-S.; PEI-MING YANG; Chen D.-S.; Sheu J.-C. |
| 臺大學術典藏 |
2022-09-14T01:30:13Z |
Clinical impact of screening first-degree relatives of patients with hepatocellular carcinoma
|
CHIEN-HUNG CHEN; Huang G.-T.; Lee H.-S.; Yang P.-M.; Chen D.-S.; Sheu J.-C. |
| 嘉南藥理大學 |
2018-12 |
Clinical Impact of Sequence Type 131 in Adults with Community-Onset Monomicrobial Escherichia Coli Bacteremia
|
Wang, Jiun-Ling; Lee, Ching-Chi; Lee, Chung-Hsun; Lee, Nan-Yao; Hsieh, Chih-Chia; Hung, Yuan-Pin; Tang, Hung-Jen; Ko, Wen-Chien |
| 國立成功大學 |
2018-12 |
Clinical Impact of Sequence Type 131 in Adults with Community-Onset Monomicrobial Escherichia Coli Bacteremia
|
Wang;Jiun-Ling;Lee;Ching-Chi;Lee;Chung-Hsun;Lee;Nan-Yao;Hsieh;Chih-Chia;Hung;Yuan-Pin;Tang;Hung-Jen;Ko;Wen-Chien |
| 國立成功大學 |
2023-12 |
Clinical impact of the combination of rapid species identification and antifungal stewardship intervention in adults with candidemia
|
Jan;Hao-En;Lo;Ching-Lung;Lee;Jen-Chieh;Li;-Chi, Ming;Lin;Wen-Liang;Ko;Wen-Chien;Lee;Nan-Yao |
| 中國醫藥大學 |
2009-06-27 |
Clinical impact of UDS for pelvic reconstructive surgery
|
鄒頡龍(Chieh-Lung Chou) |
| 臺大學術典藏 |
2019-12-18T06:15:22Z |
Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study
|
MENG RUI LEE;Chih-Hsin Lee; Jann-Yuan Wang; Shih-Wei Lee; Li-Na Lee;JEN-CHUNG KO; JEN-CHUNG KO; Chih-Hsin Lee; Jann-Yuan Wang; Shih-Wei Lee; Li-Na Lee; MENG RUI LEE |
| 臺大學術典藏 |
2020-08-13T05:23:57Z |
Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study
|
Lee M.-R.; Lee L.-N.; Ko J.-C.; Lee S.-W.; JANN-YUAN WANG; Lee C.-H.; Lee M.-R.;Lee C.-H.;Jann-Yuan Wang;Lee S.-W.;Ko J.-C.;Lee L.-N. |
| 臺大學術典藏 |
2020-03-31T08:54:25Z |
Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study
|
LI-NA LEE; Ko J.-C.; Lee S.-W.; Wang J.-Y.; Lee C.-H.; Lee M.-R.; Lee M.-R.;Lee C.-H.;Wang J.-Y.;Lee S.-W.;Ko J.-C.;Li-Na Lee |
| 臺大學術典藏 |
2021-01-08T01:57:12Z |
Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study
|
Lee L.-N.; MENG-RUI LEE; Lee C.-H.; Wang J.-Y.; Lee S.-W.; Ko J.-C. |
| 臺大學術典藏 |
2021-03-11T07:58:26Z |
Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study
|
Lee M.-R.; Lee C.-H.; Wang J.-Y.; Lee S.-W.; JEN-CHANG KO; Lee L.-N. |
| 臺大學術典藏 |
2021-03-11T08:29:31Z |
Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study
|
Lee M.-R.; Lee C.-H.; Wang J.-Y.; Lee S.-W.; JEN-CHANG KO; Lee L.-N. |
| 臺大學術典藏 |
2021-03-11T08:34:17Z |
Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study
|
Lee M.-R.;Lee C.-H.;Wang J.-Y.;Lee S.-W.;Jen-Chang Ko;Lee L.-N.; Meng-Rui Lee; Lee C.-H.; Wang J.-Y.; Lee S.-W.; JEN-CHANG KO; Lee L.-N. |
| 臺大學術典藏 |
2021-03-12T02:28:22Z |
Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study
|
Lee M.-R.;Lee C.-H.;Wang J.-Y.;Lee S.-W.;Ko J.-C.;Li-Na Lee; Lee M.-R.; Lee C.-H.; Wang J.-Y.; Lee S.-W.; Ko J.-C.; LI-NA LEE |
| 臺大學術典藏 |
2021-09-17T02:50:54Z |
Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study
|
MENG-RUI LEE; Lee C.-H.; Wang J.-Y.; Lee S.-W.; Ko J.-C.; Lee L.-N. |
| 臺大學術典藏 |
2021-10-04T07:15:39Z |
Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study
|
Lee M.-R.; Lee C.-H.; Wang J.-Y.; Lee S.-W.; JEN-CHANG KO; Lee L.-N. |
| 臺大學術典藏 |
2002 |
Clinical impact of [18F]FDG-PET in patients with suspected recurrent breast cancer based on asymptomatically elevated tumor marker serum levels: A preliminary report
|
Liu C.-S.; Shen Y.-Y.; Lin C.-C.; RUOH-FANG YEN; Kao C.-H.; Liu C.-S.;Shen Y.-Y.;Lin C.-C.;Ruoh-Fang Yen;Kao C.-H. |
